Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Solving Global Research Challenges with Artificial Intelligence

Posted on January 8th, 2018 by

Pharma R&D

board-1364652_1280

In the 21st century, we are facing a number of enormous global challenges. Simply producing enough food and clean water to nourish the planet’s growing population is one of the biggest difficulties. Meanwhile, we must also deal with the ravages of climate change and take on medical problems like antibiotic resistance. Continue reading “Solving Global Research Challenges with Artificial Intelligence” »

Unifying Data Standards to Promote Innovation

Posted on January 5th, 2018 by

Pharma R&D

blur-1853262_1280

Imagine that you are spending your days as a researcher in the life sciences, trying to use your skills, expertise and determination to do innovative, potentially life-saving work, but then you keep getting bogged down by the “busy work” of having to clean up data. Continue reading “Unifying Data Standards to Promote Innovation” »

Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle

Posted on December 22nd, 2017 by

Pharma R&D

dna-1811955_960_720

Our genetic make-up, where we live and how we live, are all important factors to consider when we are dealing with disease. For a very long time, medicine has mostly been designed to treat the sickness without much thought to the individual who has it. Continue reading “Quantitative Proteomics: A Major Piece in the Precision Medicine Puzzle” »

Compound Discovery May Spur Therapies for Autoimmune Conditions

Posted on December 20th, 2017 by

Pharma R&D

diabetes-2994808_640

People who develop autoimmune often suffer from their effects for the rest of their lives, frustrated by the lack of cure. Though there are various treatments available to help manage some of these conditions, they often don’t work very well and the disease continues to take a major toll on the patient and his or her quality of life. Continue reading “Compound Discovery May Spur Therapies for Autoimmune Conditions” »

How Pharma Can Make the Most of Gene Tech CRISPR

Posted on December 18th, 2017 by

Pharma R&D

puzzle-2500333_960_720

The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. Continue reading “How Pharma Can Make the Most of Gene Tech CRISPR” »

Chemists Concerned About How Their Field is Viewed

Posted on December 13th, 2017 by

Chemistry

Chemistry Opinion Survey 2017-12-11 15-06-07

Chemistry and its importance in everyday life is often underrated at best, and wildly misunderstood at worst. The stock image of scientists in white lab coats holding beakers of toxic chemicals has been hard to shake Continue reading “Chemists Concerned About How Their Field is Viewed” »

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 54


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.